Home › Major Depressive Disorder › District of Columbia
Major Depressive Disorder clinical trials in District of Columbia
3 studies for Major Depressive Disorder are looking for participants at sites in District of Columbia.
Cities in District of Columbia
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Children's National Medical Center, Washington D.C.
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 25, 2026 · NCT07227454Mindful Self-Compassion for Anxiety Disorders and Depression
- Georgetown University Medical Center, Washington D.C.
Recruiting
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT05671419Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
- Georgetown University Medical Center, Washington D.C.
Recruiting
Ages 18 to 65 · All sexes · Updated May 5, 2026 · NCT07028216From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.